Arbor Biotechnologies Valuation Analysis: Latest Market Insights & Trends

Hill Chart Shape

Arbor Biotechnologies Valuation and Overview

Arbor Biotechnologies
Sectors
Health, BioTech, Industrial
Headquarters
20 Acorn Park Drive, Cambridge, Massachusetts, 02140, USA
CEO
Devyn Smith
Arbor Biotechnologies's mutual fund disclosures indicate a three-month moving average fund price per share of $10.19 as of December 30, 2024, according to PM Insights' market data.
Register today to view the full report, with more in-depth details and analytics
Latest funding round
XXXXX
XX-XX-XXXX
AV Implied Valuation
XXXXX
XX-XX-XXXX
Change since Last Round
XXXXX
XX-XX-XXXX
Secondary Activity
Low
XXXXX

Business Partnerships

Targeted Impact

Who Will Benefit?

What Comes Next?

Arbor Biotechnologies Growth Timeline

No items found.

Arbor Biotechnologies and Competition

For additional insights and information on Arbor Biotechnologies, contact us today to access the full ApeVue report.
Request the full report

Arbor Biotechnologies Market Inteligence Snapshot

Arbor Biotechnologies Annual Revenue & Year-Over-Year Growth Rate

Arbor Biotechnologies Secondary Market ROI (Return on Investment)

Arbor Biotechnologies Bid-Ask Volume Ratios (Private Secondary Market)

Arbor Biotechnologies Mutual Fund Valuations (NAV)

Arbor Biotechnologies's mutual fund disclosures indicate a three-month moving average fund price per share of $10.19 as of December 30, 2024, according to PM Insights' market data.

Arbor Biotechnologies Funding Rounds & Cap Table Details

Register today to view the full report, with more in-depth details and analytics:
Access the full report

Arbor Biotechnologies VC / Strategic Investors

Arbor Biotechnologies Research

No items found.

Arbor Biotechnologies News

No items found.
Register today to view the full Arbor Biotechnologies report, with more in-depth details and analytics:
Access the full Arbor Biotechnologies report

Ready to see it in action?

Schedule a demo with one of our experts